Assessment of Quinidine‐Induced Torsades de Pointes Risks Using a Whole‐Body Physiologically Based Pharmacokinetic Model Linked to Cardiac Ionic Current Inhibition

Documenti analoghi

• Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA
  di: Polly Paul, et al.
  Pubblicazione: (2025)
• Prediction of Local Drug Exposure of Dry Powder Inhaler CXG87 (budesonide/formoterol) Using Physiologically‐Based Pharmacokinetic Model
  di: Yuran Cao, et al.
  Pubblicazione: (2025)
• Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
  di: Annie Lumen, et al.
  Pubblicazione: (2024)
• A Review of Virtual Twins in Physiologically‐Based Pharmacokinetic Modeling and Simulation
  di: Emily Mannix, et al.
  Pubblicazione: (2026)
• Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
  di: Sejung Hwang, et al.
  Pubblicazione: (2024)